cholestyramine resin has been researched along with Autoimmune Diseases in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Battezzati, PM; Crosignani, A; Invernizzi, P; Podda, M; Prina, E; Selmi, C | 1 |
| Blum, HE; Kreisel, W; Opitz, OG; Thimme, R | 1 |
2 review(s) available for cholestyramine resin and Autoimmune Diseases
| Article | Year |
|---|---|
Clinical features and management of primary biliary cirrhosis.
Topics: Animals; Autoimmune Diseases; Bone Diseases, Metabolic; Cholagogues and Choleretics; Cholestyramine Resin; Disease Progression; Fatigue; Humans; Hyperlipidemias; Hypertension, Portal; Liver Cirrhosis, Biliary; Liver Transplantation; Malnutrition; Pruritus; Risk Factors; Treatment Outcome; Ursodeoxycholic Acid | 2008 |
[Cholestatic liver diseases].
Topics: Anti-Bacterial Agents; Antibodies, Antineutrophil Cytoplasmic; Anticholesteremic Agents; Antipruritics; Autoimmune Diseases; Bile Ducts; Cholagogues and Choleretics; Cholangiography; Cholangitis; Cholangitis, Sclerosing; Cholestasis; Cholestyramine Resin; Clinical Enzyme Tests; Diagnosis, Differential; Hepatitis, Autoimmune; Humans; Immunosuppression Therapy; Inflammatory Bowel Diseases; Liver Cirrhosis; Liver Cirrhosis, Biliary; Liver Transplantation; Naloxone; Naltrexone; Narcotic Antagonists; Ondansetron; Plasmapheresis; Ursodeoxycholic Acid | 2004 |